Festival of Biologics

15 - 17 October 2019 | Basel

Discover • Develop • Get to market

WHAT IS THE FESTIVAL OF BIOLOGICS

Networking

It’s not just about the conference sessions, we recognise the importance of networking.

With roundtable discussions, themed networking receptions, networking lunches and our networking app we offer plenty of opportunities to network with your peers and continue conversations in good company.

FIND OUT MORE

Conference

The Festival of Biologics brings together the pioneers doing the most innovative work within the industry and across the whole value chain, to share their unique insights with you.

The event looks at commercialising and pushing forward the entire developmental pipeline as well as focusing on the hottest new individual therapeutics.

FIND OUT MORE

Exhibition

This is the perfect platform to generate new leads, create brand awareness and launch new products. No other marketing gets you in a room with so many potential customers looking for suppliers.

Sponsorship packages are tailored to meet your specific marketing goals. And, the exhibition floor does sell out, so don’t delay.

FIND OUT MORE

Presenting

1,500+

Attendees

600+

1-2-1 Meetings

350+

Speakers

90+

Exhibitors

Co-located events

2018 SPEAKERS INCLUDED

Justin Mason-Home
Director
HPAPI Services Limited

Andy Lee
Senior Vice President and Head of Global Clinical Trial Operations
Merck

Agnete Fredriksen
President and Chief Scientific Officer
Vaccibody AS
Dr Alain Beck
Senior Director, Biologics CMC & Developability
Centre d'Immunologie Pierre Fabre

Alan Smith
Executive Vice President, Technical Operations
Bellicum Pharmaceuticals

Martin Schiestl
Chief Science Officer
Sandoz (Novartis)
Sarah Carter
Executive Director, Head of Global Study Operations
Amgen

Wendel Doubleday
Senior Director of Chemical Development
Seattle Genetics Inc

Karoline Bechtold Peters
Senior Strategy & Technology Leader - Pharmaceutical Development
Novartis
Stephen Nabarro
Head of Clinical Operations and Data Management, Centre for Drug Development
Cancer Research UK

Andreas Katopodis
CEO
Anaveon

Sarfaraz Niazi
Chairman, Professor
Karyo Biologics/UIC
Anna Tafuri
Medical Director, Translational Medicine Oncology
Bayer HealthCare

Dr David Gilham
Vice President of Research and Development
Celyad

Jonathan Sheffield
Chief Executive Officer
NIHR Clinical Research Network
Martin Axon
Principal Occupational Hygiene
Safebridge

Ildiko Ziegler
Distinguished Validation Expert
Gedeon Richter Plc

Delphine Courmier
Health Economics Director, Biosimilars
Amgen Inc
Darko Skegro
Senior Investigator
Novartis Institutes for Biomedical Research

Dr Frédéric Triebel
Chief Scientific Officer and Medical Officer
Immutep Ltd

Hans Martin Mueller
Director, BioProcess Development
MSD
James Kent
Specialist Procurement Pharmacist London & East of England
NHS England

Reinhold Maeck
Head of Corporation EH&S Regulatory Intelligence
Boehringer Ingelheim

Andreas Schreiner
Director of Validation, Manufacturing Science and Technology
Novartis Ag
Jonathan Back
Deputy Director, Project Team Lead, Drug Discovery
Glenmark Pharmaceuticals SA

Erin Federman
VP, Head of Biologics
Boehringer Ingelheim

Dr John Delaney
Executive Director, Amgen Biologics Discovery
Amgen
Joseph Eid
SVP
Bristol Myers Squibb

Ian Henshaw
Global Head of Biogen’s Biosimilars Unit
Biogen

Lioudmila Tchistiakova
Senior Director of Global Biotherapeutic Technologies
Pfizer
Jorge González Borroto
Pharmacovigilance Officer/Senior Toxicologist
Ferrer Internacional, S.A.

Dr Marjorie Shapiro
Supervisory Biologist Office of Biotechnology Products
CDER, FDA

Jonathan Underhill
Associate Director for Medicines Evidence
NICE
Dr Karin Jooss
Chief Scientific Officer
Gritstone Oncology

Lothar Germeroth
Senior Vice President and Managing Director
Juno Therapeutics GmbH, A Celgene Company

Houng Kim
head of the strategy and operations division
Celltrion Healthcare
Tina Harris
Director Data Management
Amgen Inc

Juergen Lukas
Boehringer Ingelheim

Caroline Feys
Research & Development Operations Innovation (RDO-I) Leader
Jansen
Dr M. Anthony Moody
Associate Professor of Paediatrics, Assistant Professor of Immunology
Duke University Medical Center

Partha Chowdhury
Senior Director and Head, Antibody Discovery
Sanofi Genzyme

Patrick Burke
Associate Director
Seattle Genetics Inc
Matthew Hewitt
Director, Tumour Immunology
Bellicum Pharmaceuticals

Andreas Herrmann
Chief Executive Officer
Valerius Biopharma

Leigh-Anne Blair
FORMER Senior Director - Clinical Operations
Onconova Therapeutics Inc
Thomas Thoma
Head Clinical Trials Supply
Teva Pharmaceuticals

Niklas Engler
Global Head Technical Development Portfolio and Project Management
F. Hoffmann-La Roche AG

Peter Marshall
Principal Technology Engineer
AstraZeneca
Ruediger Jankowsky
Managing Director
Cinfa Biotech

Paul Carter
Senior Director and Staff Scientist, Antibody Engineering
Genentech

Chris Gomez
Head of Health, Safety and Environmental
Hovione
Pascal Touchon
Senior Vice President and Global Head Cell & Gene
Novartis

Per Ola Freskgard
Vice Director & Expert Scientist
Roche Innovation Center Basel

Roman Drai
Director, Clinical Development
Geropharm
Mimi Choon-Quinones
Former Vice-Director, Clinical Operations EEMEA
Roche

Ghassan Karam
Project Manager
W.H.O. I.C.T.R.P.

Roland Kontermann
Professor Of Biomedical Engineering
University of Stuttgart
Jeff Parry
Senior Scientist Manufacturability
AstraZeneca

Phil Bland-Ward
Chief Scientific Officer
Crescendo Biologics Ltd

Thomas Nittoli
Director
Regeneron Pharmaceuticals
Meenu Wadhwa
Section Leader for Cyotkines and Growth Factors Section
NIBSC

Ivana Matic
Global Operations Lead- Agreements
MSD

Sung-Hye Grieco
Senior Engineer at Early Stage Cell Culture, PTD Department
Genetech
Henk Johan Streefkerk
Medical Director
PIQUR Therapeutics

Dr Shane Olwill
Vice President of Development
Pieris Pharmaceuticals

Zhaoyang Megan Li
Senior Director, Clinical Pharmacology
Shire
Roger Beerli
CSO
NBE Therapeutics

Ingrid Bourges
Clinical Assessor
Federal Agency for Medicines and Health Products

Jan Pieter Kappelle
Senior Director Global Clinical Supplies
UCB Pharma
Louis Boon
Chief Scientific Officer
Bioceros

Ulrich Scholz
Head of Scale Up and Processing
Bayer

Disa Lee Choun
Head of Innovation, GCSO
UCB
Adama Ibrahim
Senior Clinical Operations Lead
Biogen

Tim Cave
VP-Head Strategic Planning and Digital Practices, Global Medical Affairs
GSK

SEE ALL SPEAKERS

Sponsors can access hundreds of senior decision makers from across the whole biologics community. Join us!

Who Attends

AbbVie Abzena ADC Therapeutics Alligator Bioscience Amgen AstraZeneca Biogen Biosim Spanish Association of Biosimilars Boehringer Ingelheim Bristol Myers Squibb Cancer Research UK Cinfa Biotech GmbH Dr. Reddy's Laboratories SA. Duke University Medical Centre Eli Lilly & Co European Molecular Biology Laboratory European Patent Office European Specialist Nurses Organisations Ferrer International Fraunhofer IME Gedeon Richter Goldstein & Fox GSK HPAPI Project Services Ltd Janssen Libbs Pharmaceutica Lonza mAbs Macrogenics Maverick Therapeutics MedImmune Merck Merck, Sharp & Dohme (MSD) Napp pharmaceuticals NAPP Pharmaceuticals NBE Therapeutics NHS NIBR NICE NIHR Clinical Research Network (NIHR CRN) Norwegian Medicines Agency Novartis NovImmune NxR Biotechnologies Opsona Therapeutics Oril Industrie Ossianix PAREXEL Paul Ehrlich Institute Pfizer Biotherapeutics Pieris Pharmaceuticals Pierre Fabre Prima BioMed Roche Roche S.A.Toral SafeBridge Sandoz Biopharmaceuticals Sandoz Sanofi Sanofi R&D Sanquin Seattle Genetics Technische Universität Braunschweig Teva Pharmaceuticals The Royal Marsden NHS Foundation Trust Therapeomic TU Wien UCB Celltech University of Cambridge University of Denmark University of Messina – Italy University of Stuttgart